Sanchez Reyna A, Mendoza-Gonzalez R, Luna-Garcia H, Celaya Padilla J, Morgan Benita J, Espino-Salinas C
PeerJ Comput Sci. 2025; 10:e2437.
PMID: 39896407
PMC: 11784714.
DOI: 10.7717/peerj-cs.2437.
Mirzaei M, Ahmadi N, Bagheri Fahraji B, Ardekani A, Rahimdel A, Soltani M
Sci Rep. 2024; 14(1):28837.
PMID: 39572624
PMC: 11582726.
DOI: 10.1038/s41598-024-79616-4.
Chadani Y, Fujito R, Kimura N, Kawai R, Kashibayashi T, Takahashi R
Sci Rep. 2024; 14(1):21290.
PMID: 39266605
PMC: 11392955.
DOI: 10.1038/s41598-024-71440-0.
Kopcanova M, Tait L, Donoghue T, Stothart G, Smith L, Sandoval A
bioRxiv. 2023; .
PMID: 37398162
PMC: 10312609.
DOI: 10.1101/2023.06.11.544491.
Watanabe H, Hikida S, Ikeda M, Mori E
Front Neurol. 2023; 14:1128566.
PMID: 37077573
PMC: 10106638.
DOI: 10.3389/fneur.2023.1128566.
Identifying prognostic indicators for cognitive stimulation therapy for dementia: protocol for a systematic review and individual participant data meta-analysis.
Crawley D, Saunders R, Buckman J, Hui E, Walker R, Dotchin C
BJPsych Open. 2023; 9(3):e69.
PMID: 37066632
PMC: 10134233.
DOI: 10.1192/bjo.2023.46.
Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
Hort J, Duning T, Hoerr R
Neuropsychiatr Dis Treat. 2023; 19:647-660.
PMID: 36994422
PMC: 10041984.
DOI: 10.2147/NDT.S401231.
Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia.
Agarwal A, Mishra B, Gupta A, Srivastava M, Basheer A, Sharma J
Front Aging Neurosci. 2023; 15:1134775.
PMID: 36936504
PMC: 10014812.
DOI: 10.3389/fnagi.2023.1134775.
Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
Karamacoska D, Chan D, Leung I, Liu J, Brodaty H, Fahey P
PLoS One. 2023; 18(3):e0265285.
PMID: 36920949
PMC: 10016672.
DOI: 10.1371/journal.pone.0265285.
DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders.
Martinez-Iglesias O, Naidoo V, Corzo L, Pego R, Seoane S, Rodriguez S
Genes (Basel). 2023; 14(2).
PMID: 36833292
PMC: 9956161.
DOI: 10.3390/genes14020365.
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
Colwell M, Tagomori H, Chapman S, Gillespie A, Cowen P, Harmer C
Transl Psychiatry. 2022; 12(1):484.
PMID: 36396622
PMC: 9671959.
DOI: 10.1038/s41398-022-02249-6.
Influencing factors on instrumental activities of daily living functioning in people with mild cognitive disorder - a secondary investigation of cross-sectional data.
Bruderer-Hofstetter M, Gorus E, Cornelis E, Meichtry A, De Vriendt P
BMC Geriatr. 2022; 22(1):791.
PMID: 36217106
PMC: 9552428.
DOI: 10.1186/s12877-022-03476-8.
How segmentation methods affect hippocampal radiomic feature accuracy in Alzheimer's disease analysis?.
Zheng Q, Zhang Y, Li H, Tong X, Ouyang M
Eur Radiol. 2022; 32(10):6965-6976.
PMID: 35999372
DOI: 10.1007/s00330-022-09081-y.
Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments.
Hoang K, Watt H, Golemme M, Perry R, Ritchie C, Wilson D
Trials. 2022; 23(1):623.
PMID: 35915506
PMC: 9340683.
DOI: 10.1186/s13063-022-06190-3.
Unclassified fluent variants of primary progressive aphasia: distinction from semantic and logopenic variants.
Watanabe H, Hikida S, Ikeda M, Mori E
Brain Commun. 2022; 4(3):fcac015.
PMID: 35686225
PMC: 9171501.
DOI: 10.1093/braincomms/fcac015.
Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial.
Yang Z, Zhang W, Liu D, Zhang S, Tang Y, Song J
Front Aging Neurosci. 2022; 14:910261.
PMID: 35645781
PMC: 9133718.
DOI: 10.3389/fnagi.2022.910261.
Effects of different kinds of anti-Alzheimer's disease drugs on cognitive improvement: protocol for a systematic review and network meta-analysis of phase III clinical trials.
Lyu D, Gong M, Zhang Y, Lyu X
Syst Rev. 2022; 11(1):84.
PMID: 35501927
PMC: 9063050.
DOI: 10.1186/s13643-022-01964-x.
Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.
Garcia-Martin V, de Hoyos-Alonso M, Ariza-Cardiel G, Delgado-Puebla R, Garcia-Domingo P, Hernandez-Melo E
BMC Geriatr. 2022; 22(1):71.
PMID: 35065615
PMC: 8783993.
DOI: 10.1186/s12877-022-02762-9.
Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer's Disease.
Zhang W, Zhang T, Pan T, Zhao S, Nie B, Liu H
Front Aging Neurosci. 2022; 13:764272.
PMID: 34975455
PMC: 8715958.
DOI: 10.3389/fnagi.2021.764272.
Protocol for thiamine and folic acid in the treatment of cognitive impairment in maintenance haemodialysis patients: a prospective, randomised, placebo-controlled, double-blind, multicentre study.
Lu R, Gu L, Zhang W, Guo Y, Zang X, Zhou Y
BMJ Open. 2021; 11(12):e050605.
PMID: 34907051
PMC: 8671988.
DOI: 10.1136/bmjopen-2021-050605.
